GDRX Goodrx Holdings Inc

$2.85

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/18/2025

About Goodrx Holdings Inc

GoodRx Holdings, Inc. provides information and tools that allow consumers to compare prices and save when buying prescription drugs in the United States. The company is headquartered in Santa Monica, California.

Website: https://www.goodrx.com

Sector
TECHNOLOGY
Industry
SERVICES-COMPUTER PROCESSING & DATA PREPARATION
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1809519
Address
233 WILSHIRE BLVD., SUITE 990, SANTA MONICA, CA, US
Valuation
Market Cap
$1.72B
P/E Ratio
112.12
PEG Ratio
nan
Price to Book
2.37
Performance
EPS
$0.04
Dividend Yield
—
Profit Margin
2.07%
ROE
2.20%
Technicals
50D MA
$4.64
200D MA
$5.92
52W High
$9.26
52W Low
$3.82
Fundamentals
Shares Outstanding
107M
Target Price
$6.62
Beta
1.26

GDRX EPS Estimates vs Actual

● Estimated
● Actual

GDRX News & Sentiment

Nov 17, 2025 • Benzinga NEUTRAL
Novo Nordisk Leans Into Affordability Amid Rising Competition - Novo Nordisk ( NYSE:NVO )
Novo Nordisk A/S ( NYSE:NVO ) announced on Monday that Wegovy ( semaglutide ) injection 0.25 mg and 0.5 mg and Ozempic are now available at a limited-time price of $199 per month to new self-pay patients between now and March 31, 2026.
Nov 17, 2025 • CNBC NEUTRAL
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month
The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s easier for Americans to access.
Nov 05, 2025 • Benzinga SOMEWHAT-BULLISH
Novo Nordisk Q3 2025 Earnings Call Transcript - Novo Nordisk ( NYSE:NVO )
Novo Nordisk A/S ( NASDAQ:NVO ) reported third-quarter financial results on Wednesday. The transcript from the company's third-quarter earnings call has been provided below. NVO is having a challenging session. See if it is worth your attention here.
Nov 04, 2025 • Zacks Commentary SOMEWHAT-BULLISH
GoodRx Holdings, Inc. ( GDRX ) Misses Q3 Earnings Estimates
GoodRx (GDRX) delivered earnings and revenue surprises of -11.11% and +1.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 31, 2025 • Zacks Commentary BULLISH
Hims & Hers Scales AI-Driven Personalized Health and Wellness
HIMS scales AI-driven care with new hormonal health lines, global expansion plans and a $870 million funding boost.
Oct 09, 2025 • Benzinga SOMEWHAT-BULLISH
Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch - GoodRx Holdings ( NASDAQ:GDRX )
Prescription savings platform GoodRx Holdings Inc. ( NASDAQ:GDRX ) is reportedly joining the so-called TrumpRx website, signaling an initiative expansion beyond pharmaceutical manufacturers' direct discount programs.
Sentiment Snapshot

Average Sentiment Score:

0.269
50 articles with scored sentiment

Overall Sentiment:

Bullish

GDRX Reported Earnings

Aug 06, 2025
Jun 30, 2025 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.09
  • Estimate: $0.10
  • Whisper: —
  • Surprise %: -10.0%
May 07, 2025
Mar 31, 2025 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.09
  • Estimate: $0.10
  • Whisper: —
  • Surprise %: -6.0%
Feb 27, 2025
Dec 31, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.09
  • Estimate: $0.10
  • Whisper: —
  • Surprise %: -6.2%
Nov 07, 2024
Sep 30, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.08
  • Estimate: $0.09
  • Whisper: —
  • Surprise %: -11.1%
Aug 08, 2024
Jun 30, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.08
  • Estimate: $0.09
  • Whisper: —
  • Surprise %: -11.1%
May 09, 2024
Mar 31, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $0.08
  • Estimate: $0.08
  • Whisper: —
  • Surprise %: 0.0%
Feb 29, 2024
Dec 31, 2023 (Pre market)
0.01 Surprise
  • Reported EPS: $0.08
  • Estimate: $0.07
  • Whisper: —
  • Surprise %: 14.3%
Nov 09, 2023
Sep 30, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $0.06
  • Estimate: $0.06
  • Whisper: —
  • Surprise %: 0.0%
Aug 09, 2023
Jun 30, 2023 (Pre market)
0.01 Surprise
  • Reported EPS: $0.07
  • Estimate: $0.06
  • Whisper: —
  • Surprise %: 16.7%

Financials